Editas Medicine struggles with underwhelming data and lacks major partnerships. Find out why EDIT stock faces significant ...

The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...

CRISPR-Cas systems are prokaryotic immune systems that confer resistance to foreign genetic elements such as plasmids and phages. CRISPR-Cas systems have been exploited for targeted genome editing ...

Recursion Pharmaceuticals uses artificial intelligence (AI) in its proprietary operating system to match new compounds ...

At meeting on human embryo editing, CRISPR pioneer says science is a long way from knowing if germline DNA can be safely ...

This study provides a potentially useful investigation into the positive role of BDNF/TrkB signaling in implanted dental pulp stem cells to enhance dentin regeneration in the context of dental caries.

The timelines are estimates and reflect how long it takes the IRCC to process most complete applications of the specific type. The processing timeline starts the day the IRCC receives the complete ...

In the business of homebuilding, we have plenty of conversations about costs — but what about time? Not to say cost isn’t important, but time is really where money tends to go, and profit bleeds with ...

New Delhi: The Defence Ministry Thursday cleared a proposal to cut down procurement timelines by half, which will be incorporated in the new Defence Acquisition Procedure (DAP) likely to be issued ...

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

The company’s proprietary CRISPR technology and its focus on HLA-matching hypothesis validation set ... but they can lead to uncertainty regarding the efficacy of the treatment and the company’s ...

The company’s proprietary CRISPR technology and its focus on HLA ... treatment and the company’s ability to meet development timelines. This delay may cause some investors to adopt a more ...